Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Faculty of Medicine, University Hospital Carl Gustav Carus, OncoRay - National Center for Radiation Research in Oncology, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Dresden, Germany.
Med Phys. 2019 Mar;46(3):1140-1149. doi: 10.1002/mp.13371. Epub 2019 Feb 4.
Motion-induced uncertainties hamper the clinical implementation of pencil beam scanning proton therapy (PBS-PT). Prospective pretreatment evaluations only provide multiscenario predictions without giving a clear conclusion for the actual treatment. Therefore, in this proof-of-concept study we present a methodology for a fraction-wise retrospective four-dimensional (4D) dose reconstruction and accumulation aiming at the evaluation of treatment quality during and after treatment.
We implemented an easy-to-use, script-based 4D dose assessment of PBS-PT for patients with moving tumors in a commercially available treatment planning system. This 4D dose accumulation uses treatment delivery log files and breathing pattern records of each fraction as well as weekly repeated 4D-CT scans acquired during the treatment course. The approach was validated experimentally and was executed for an exemplary dataset of a lung cancer patient.
The script-based 4D dose reconstruction and accumulation was implemented successfully, requiring minimal user input and a reasonable processing time (around 10 min for a fraction dose assessment). An experimental validation using a dynamic CIRS thorax phantom confirmed the precision of the 4D dose reconstruction methodology. In a proof-of-concept study, the accumulation of 33 reconstructed fraction doses showed a linear increase of D98 values. Projected treatment course D98 values revealed a CTV underdosage after fraction 25. This loss of target coverage was confirmed in a dose volume histogram comparison of the nominal, the projected (after 16 fractions) and the accumulated (after 33 fractions) dose distribution.
The presented method allows for the assessment of the conformity between planned and delivered dose as the treatment course progresses. The implemented approach considers the influence of changing patient anatomy and variations in the breathing pattern. This facilitates treatment quality evaluation and supports decisions regarding plan adaptation. In a next step, this approach will be applied to a larger patient cohort to investigate its capability as 4D quality control and decision support tool for treatment adaptation.
运动引起的不确定性阻碍了笔形束扫描质子治疗(PBS-PT)的临床应用。前瞻性的预处理评估仅提供多场景预测,而不能为实际治疗提供明确的结论。因此,在这项概念验证研究中,我们提出了一种用于分次回顾性四维(4D)剂量重建和积累的方法,旨在评估治疗过程中和治疗后的治疗质量。
我们在商业上可用的治疗计划系统中为移动肿瘤患者实现了一种易于使用的基于脚本的 PBS-PT 4D 剂量评估。这种 4D 剂量积累使用了每个分次的治疗交付日志文件和呼吸模式记录,以及在治疗过程中每周重复进行的 4D-CT 扫描。该方法经过了实验验证,并针对肺癌患者的示例数据集进行了执行。
基于脚本的 4D 剂量重建和积累成功实现,需要最小的用户输入和合理的处理时间(大约 10 分钟即可评估一个分次的剂量)。使用动态 CIRS 胸部体模进行的实验验证证实了 4D 剂量重建方法的精度。在概念验证研究中,33 个重建分次剂量的积累显示 D98 值呈线性增加。预计治疗过程中的 D98 值显示 CTV 在第 25 次分次后出现剂量不足。在名义剂量、预计剂量(16 次分次后)和积累剂量(33 次分次后)分布的剂量体积直方图比较中,证实了靶区覆盖的损失。
所提出的方法允许随着治疗过程的进展评估计划剂量与实际剂量之间的一致性。所实施的方法考虑了患者解剖结构变化和呼吸模式变化的影响。这有助于治疗质量评估,并支持关于计划调整的决策。在下一步中,将该方法应用于更大的患者队列,以研究其作为 4D 质量控制和计划调整决策支持工具的能力。